P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy

Human Pathology, 05/14/2012

Immunohistochemical expression of P16 significantly correlates with chemotherapy response in osteosarcoma. P16 expression may be a useful biomarker to guide treatment selection.

Print Article Summary